What is NDC 82293-029?

82293-029 is the product NDC for Sacubitril and Valsartan, Sacubitril 97 mg/1; Valsartan 103 mg/1 tablet, film coated, listed with the FDA by Novugen Pharma (USA) LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Novugen Pharma (USA) LLC, NDC labeler code 82293. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sacubitril and Valsartan?

89 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sacubitril and Valsartan NDC 82293-029

NDC codes

FDA NDC Directory

Product NDC (as listed)82293-029Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82293-0029Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
82293-029-10	8229300291082293002910	60 TABLET, FILM COATED in 1 BOTTLE (82293-029-10)Marketed from Jul 16, 2025
82293-029-20	8229300292082293002920	180 TABLET, FILM COATED in 1 BOTTLE (82293-029-20)Marketed from Jul 16, 2025
82293-029-30	8229300293082293002930	100 BLISTER PACK in 1 BOX, UNIT-DOSE (82293-029-30) / 10 TABLET, FILM COATED in 1 BLISTER PACK (82293-029-31)Marketed from Jul 16, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sacubitril and Valsartan
Generic name (nonproprietary): sacubitril and valsartan
Active ingredients: Sacubitril — 97 mg/1Valsartan — 103 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Novugen Pharma (USA) LLCNDC labeler code 82293
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213611
Marketing start: Jul 16, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Neprilysin Inhibitors (Mechanism)
Identifiers: Product ID 82293-029_4d34c331-a1f9-937a-e063-6294a90a66b7SPL ID 4d34c331-a1f9-937a-e063-6294a90a66b7SPL set ID 747eeb5c-ac2f-474f-b6d2-0586d12653a6RxCUI 1656340, 1656349, 1656354UNII 17ERJ0MKGI, 80M03YXJ7IUPC 0382293028207, 0382293029105, 0382293029204
Pharmacologic class: Angiotensin 2 Receptor Blocker; Neprilysin Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482293002910 followed by a unit qualifier and the quantity

Package 82293-0029-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Sacubitril and valsartan tablets are a combination of sacubitril, a neprilisin inhibitor, and valsartan, an angiotensin II receptor blocker, and is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal. ( 1.1 ) for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. Sacubitril and valsartan tablets reduce NT-proBNP and is expected to improve cardiovascular outcomes. ( 1.2 ) 1.1 Adult Heart Failure Sacubitril and vals…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82293-029

What is NDC 82293-029?: 82293-029 is the product NDC for Sacubitril and Valsartan, Sacubitril 97 mg/1; Valsartan 103 mg/1 tablet, film coated, listed with the FDA by Novugen Pharma (USA) LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sacubitril and Valsartan.
What is the active ingredient?: Sacubitril, Valsartan.
Who is the labeler?: Novugen Pharma (USA) LLC, NDC labeler code 82293. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sacubitril and Valsartan?: 89 other product NDCs are listed under this name. See all Sacubitril and Valsartan NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sacubitril and Valsartan NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-082	84386-0082-1884386-0082-6084386-0082-78
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-081	84386-0081-1884386-0081-6084386-0081-78
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-083	84386-0083-1884386-0083-6084386-0083-78
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-087	60290-0087-0160290-0087-0260290-0087-03
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-085	60290-0085-0160290-0085-0260290-0085-03
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-086	60290-0086-0160290-0086-0260290-0086-03
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-880	72603-0880-0172603-0880-02
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-881	72603-0881-0172603-0881-02
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-882	72603-0882-0172603-0882-02
sacubitril and valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-937	51407-0937-10

All 90 Sacubitril and Valsartan NDCs

Other NDCs under ANDA 213611

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213611
Product	Strength	Form · route	Labeler	Product NDC
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-955
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-966
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-977
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	Novugen Pharma (USA) LLC	82293-027
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	Novugen Pharma (USA) LLC	82293-028
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	Novugen Pharma (USA) LLC	82293-040